Uses
Benzamycin Topical Gel is indicated for the topical treatment of acne vulgaris.
Source: US FDA prescribing information
Fixed-dose combination
Benzoyl peroxide and Erythromycin is a fixed-dose combination of a macrolide antimicrobial and a macrolide indicated for the topical treatment of acne vulgaris. It is available as kits and gel for topical use. MedsAcross supplies Benzoyl peroxide and Erythromycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Benzamycin Topical Gel is indicated for the topical treatment of acne vulgaris.
Source: US FDA prescribing information
Benzamycin Topical Gel should be applied twice daily, morning and evening, or as directed by a physician, to affected areas after the skin is thoroughly washed, rinsed with warm water and gently patted dry.
Source: US FDA prescribing information
Benzamycin Topical Gel is contraindicated in those individuals who have shown hypersensitivity to any of its components.
Source: US FDA prescribing information
Pseudomembranous colitis has been reported with nearly all antibacterial agents, including erythromycin, and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with diarrhea subsequent to the administration of antibacterial agents. Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is one primary cause of “antibiotic-associated colitis”. After the diagnosis of pseudomembranous colitis has been established, therapeutic measures should be initiated. Mild cases of pseudomembranous colitis usually respond to drug discontinuation alone.
Source: US FDA prescribing information
In controlled clinical trials, the incidence of adverse reactions associated with the use of Benzamycin Topical Gel was approximately 3%. These were dryness and urticarial reaction. The following additional local adverse reactions have been reported occasionally: irritation of the skin including peeling, itching, burning sensation, erythema, inflammation of the face, eyes and nose, and irritation of the eyes. Skin discoloration, oiliness and tenderness of the skin have also been reported.
Source: US FDA prescribing information
Add indicated amount of room temperature 70% ethyl alcohol to vial (to the mark) and immediately shake to completely dissolve erythromycin. Benzamycin Topical Gel should then be stored under refrigeration. Do not freeze. Do not freeze. NOTE: Prior to reconstitution, store at room temperature between 15° to 30°C (59° to 86°F). After reconstitution, store under refrigeration between 2° to 8°C (36° to 46°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
3 presentations of Benzoyl peroxide and Erythromycin, sorted by availability.
| Medicine | Active ingredient | Manufacturer | Register | Availability |
|---|---|---|---|---|
| Benzoyl peroxide and Erythromycin kitGeneric name | Benzoyl peroxide and Erythromycin | — | US FDA | Available on request |
| Benzoyl peroxide and Erythromycin 50 mg/30 mg per g gelTopical Cold chainGeneric name | Benzoyl peroxide and Erythromycin | — | US FDA | Available on request |
| Benzamycin kit Cold chain | Benzoyl peroxide and Erythromycin | Bausch Health | US FDA | Available on request |
1 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 26 October 1984 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 3 presentations of Benzoyl peroxide and Erythromycin and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 1 brand names for Benzoyl peroxide and Erythromycin, including Benzamycin.
Yes. The US FDA first approved Benzoyl peroxide and Erythromycin on 26 October 1984, according to Drugs@FDA.
At least one listed presentation of Benzoyl peroxide and Erythromycin must be kept cold, so it is shipped in temperature-controlled packaging. Check the storage line on each presentation.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.